Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $10.56 USD
Change Today -0.36 / -3.30%
Volume 855.1K
AFFX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

affymetrix inc (AFFX) Snapshot

Open
$10.98
Previous Close
$10.92
Day High
$11.02
Day Low
$10.53
52 Week High
03/17/15 - $13.11
52 Week Low
10/15/14 - $7.00
Market Cap
816.5M
Average Volume 10 Days
907.9K
EPS TTM
$0.13
Shares Outstanding
77.3M
EX-Date
--
P/E TM
79.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for AFFYMETRIX INC (AFFX)

affymetrix inc (AFFX) Related Businessweek News

No Related Businessweek News Found

affymetrix inc (AFFX) Details

Affymetrix, Inc. provides life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein, and cell level primarily in the United States, Europe, Latin America, and Asia. The company operates in two segments, Affymetrix Core and eBioscience. The Affymetrix Core segment engages in the development, manufacture, and commercialization of systems for genetic analysis in the life sciences and diagnostic industry. This segment develops and markets GeneChip gene expression products and services; genotyping product line; products with clinical diagnostic and research applications, such as the CytoScan and OncoScan products; GeneTitan instrument system that runs genotyping and gene expression array plates; and QuantiGene line of singleplex and multiplex assays to serve customers in the research and translational medicine markets. It also offers life science reagents, such as ExoSAP-IT for a reagent for the clean-up of polymerase chain reaction, and HotStart-IT reagents to inhibit primer dimer formation; enzymes; purification kits; and biochemicals for life science researchers and other biological and health care manufacturers. The eBioscience segment is involved in the development, manufacturing, marketing, and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging, and other protein-based analyses. This segment offers a portfolio of antibodies and reagents, as well as a range of the QuantiGene and Procarta Plex assays for low to mid-plex experiments. The company sells its products directly and through third party distributors to genomic research centers, academic institutions, government, and private laboratories, as well as pharmaceutical, diagnostic, and biotechnology companies. Affymetrix, Inc. was founded in 1991 and is headquartered in Santa Clara, California.

1,100 Employees
Last Reported Date: 04/30/15
Founded in 1991

affymetrix inc (AFFX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $549.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $349.8K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $399.8K
Chief Commercial Officer and Executive Vice P...
Total Annual Compensation: $349.8K
Compensation as of Fiscal Year 2014.

affymetrix inc (AFFX) Key Developments

Affymetrix Inc. Appoints Board of Directors

On May 13, 2015, the Board of Directors of Affymetrix elected Riccardo Pigliucci to the Board of Directors of the company and appointed Mr. Pigliucci a member of its Compensation Committee. Mr. Pigliucci will participate in the company's compensation program for non-employee directors, as amended, including an annual retainer of $45,000, and an initial award of options to purchase 30,000 shares of the company's common stock, which will vest and become exercisable in equal installments on each of the first three anniversaries of the date of grant, subject to Mr. Pigliucci's continued service on the Board through each vesting date. Mr. Pigliucci has served as the Managing Partner of Aldwych Associates, LLP since 2006. Prior to joining Aldwych Associates, LLP and since 2005, he served as an independent consultant. Mr. Pigliucci was Chairman and Chief Executive Officer of Discovery Partners International Inc. from 1998 until 2005. Mr. Pigliucci currently serves as Chairman of the Board of Directors of Medaphor PLC. The Board of Directors values Mr. Pigliucci's experience in the life sciences and healthcare equipment industry. The annual meeting of the stockholders of the company was held on May 13, 2015. At the Meeting, the stockholders elected Frank Witney as nominee as director.

Affymetrix Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-14-2015 09:20 AM

Affymetrix Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-14-2015 09:20 AM. Venue: Encore at the Wynn, 3131 S Las Vegas Blvd, Las Vegas, Nevada, United States. Speakers: Andy Last, Chief Operating Officer.

Affymetrix Mulls Acquisitions

Affymetrix Inc. (NasdaqGS:AFFX) is seeking acquisitions. Andy Last, Executive Vice President, said, "Strengthening our balance sheet to stage us for what we are now in, which we are calling our Phase 3 of our roadmap beginning of this year, where we wish to, obviously, deliver sustainable, profitable growth, and then expand in our market segments of choice and increase our ability to make small tuck-ins and acquisitions."

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AFFX:US $10.56 USD -0.36

AFFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Fluidigm Corp $23.43 USD -0.77
Foundation Medicine Inc $33.88 USD +0.04
Luminex Corp $17.33 USD +0.07
Sequenom Inc $3.00 USD -0.045
Takara Bio Inc ¥1,385 JPY -5.00
View Industry Companies
 

Industry Analysis

AFFX

Industry Average

Valuation AFFX Industry Range
Price/Earnings 74.0x
Price/Sales 2.3x
Price/Book 2.8x
Price/Cash Flow 76.4x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AFFYMETRIX INC, please visit www.affymetrix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.